Novak Djokovic has an 80% stake in a Danish biotech firm which is working on a Covid-19 treatment.
The world No. 1 and coronavirus have been on an eventful journey, with the Serbian deported from Australia and denied the chance to defend his Australian Open title.
His visa was cancelled on “health and good order grounds” - with there being a furore over Djokovic not being vaccinated.
'We are getting old' - Federer, Nadal, Djokovic pay tribute to retiring Tsonga
- He tries really hard to do right- Konta on Djokovic
- Azarenka calls for vaccine mandate after Djokovic saga
He is now back in Serbia, while it is not clear whether he will be able to defend his French Open crown, after France ruled that all participants in sport must be vaccinated against Covid-19.
And while being in Serbia, the CEO of QuantBioRes, Ivan Loncarevic said Djokovic made his investment in the summer of 2020.
Loncarevic also told Reuters that the company was working on a treatment as opposed to a vaccine, and was hopeful of being given the green light to launch clinical trials for its peptide in Britain this summer.
- - -
Stream the 2022 Australian Open live and on demand on discovery+. A subscription for discovery+ is now £29.99 for the first year for UK users, down from £59.99
'Nobody can compare with Nadal, Federer' - Gasquet on greats of tennis
'He wanted to send a message' - Zverev on fired-up Djokovic threat
Share this article